The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

6 articles for PM Keller


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Azepanone-based inhibitors of human cathepsin S: optimization of selectivity via the P2 substituent.EBI
Glaxosmithkline
Discovery of potent, selective sulfonylfuran urea endothelial lipase inhibitors.EBI
Glaxosmithkline
Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitors.BDB
Dupont Pharmaceuticals
2-Amino-6-arylsulfonylbenzonitriles as non-nucleoside reverse transcriptase inhibitors of HIV-1.BDB
Glaxosmithkline
Nonpeptide cyclic cyanoguanidines as HIV-1 protease inhibitors: synthesis, structure-activity relationships, and X-ray crystal structure studies.BDB
Dupont Pharmaceuticals
Stereoisomers of cyclic urea HIV-1 protease inhibitors: synthesis and binding affinities.BDB
Dupont Pharmaceuticals